Presentations & Publications
// Feb 02, 2025 | Presentation
3rd Viral Vector Process Development & Manufacturing Summit Boston, MA
Novel Approach to Treating Rare Disease Using an AAV Vector to Deliver Gene Editing Tools to the Brain
// Jan 31, 2025 | Presentation
5th Annual Summit of Biologics Conference and Workshop on Biopharmaceutical Product Development Goa, India
Potency Development for Cell & Gene Therapy Products
// Jan 21, 2025 | Webinar
Phacilitate Advanced Therapies Week Dallas, Texas
Driving Innovation and Scalability In Advanced Therapies
// Nov 07, 2024 | Presentation
31st Annual Meeting of the Huntington Study Group Cincinnati, OH
Allele-selective editing of mHTT utilizing AAV5-delivered Life Edit®️ CRISPR System (LETI-101) results in meaningful reduction of mHTT protein
// Oct 24, 2024 | Webinar
Outsourced Pharma Capacity Update
How to Navigate the Successful Transition from Clinical to Commercial Manufacturing in Cell Therapy
// Oct 16, 2024 | Presentation
Formulation & Delivery U.S. 2024 Conference San Diego, CA
Enabling In Vivo Gene Editing with Proprietary Lipid Nanoparticles (LNPs)
// September 23-26, 2024 | Presentation
BioProcess International 2024 Boston, MA
Generation, Characterization, and Stability of iPSC Lines
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Viral Design: Impact of Early Integration Across R&D and Process Development Workflows to Accelerate Development
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Analytical Capabilities at ElevateBio BaseCamp Utilizing LentiPeak™
// September 17-20, 2024 | Poster
9th Annual CAR-TCR Summit Boston, MA
From Clinical Success to Commercial Readiness
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
Rapid Development of Ion Exchange Chromatography for Full/Empty Separation in Adeno-Associated Virus Serotype 5
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
